Quick Answer
Whitehawk Therapeutics, Inc. reported Stockholders Equity of $136.31 million for the year ending 2025.
- Whitehawk Therapeutics, Inc. showed an increase of +159.7% in Stockholders Equity from 2024 to 2025.
- This data is from Whitehawk Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: -$114.5 thousand | Q1 2014: -$130.0 thousand | Q2 2014: -$137.0 thousand | Q3 2014: -$143.4 thousand | Q1 2015: -$160.9 thousand | Q2 2015: -$168.1 thousand | Q3 2015: -$174.6 thousand | Q1 2016: -$192.8 thousand | Q2 2016: -$200.5 thousand | Q3 2016: -$207.3 thousand | Q1 2017: $33.31 million | Q2 2017: $27.94 million | Q3 2017: $23.42 million | Q1 2018: $11.11 million | Q2 2018: $47.91 million | Q3 2018: $66.52 million | Q1 2019: $50.80 million | Q2 2019: $45.72 million | Q3 2019: $41.71 million | Q1 2020: -$12.39 million | Q2 2020: -$17.63 million | Q3 2020: -$20.49 million | Q1 2021: -$17.87 million | Q2 2021: -$19.37 million | Q3 2021: $150.93 million | Q1 2022: $124.63 million | Q2 2022: $108.73 million | Q3 2022: $169.11 million | Q1 2023: $145.99 million | Q2 2023: $131.42 million | Q3 2023: $118.20 million | Q1 2024: $90.46 million | Q2 2024: $78.79 million | Q3 2024: $68.87 million | Q1 2025: $221.73 million | Q2 2025: $172.07 million | Q3 2025: $157.17 million.
- Over the full 17 years of available data (2009 to 2025), Whitehawk Therapeutics, Inc.'s Stockholders Equity has grown by 733,112.5%.
- Historical annual values: Fiscal year 2025: $136.31 million | Fiscal year 2024: $52.48 million | Fiscal year 2023: $105.20 million | Fiscal year 2022: $158.38 million | Fiscal year 2021: $136.41 million | Fiscal year 2020: -$12.43 million | Fiscal year 2019: -$9.09 million | Fiscal year 2018: $58.67 million | Fiscal year 2017: $17.44 million | Fiscal year 2016: -$86.22 million | Fiscal year 2015: -$66.55 million | Fiscal year 2014: -$155.0 thousand | Fiscal year 2013: -$124.2 thousand | Fiscal year 2012: -$95.5 thousand | Fiscal year 2011: -$68.2 thousand | Fiscal year 2010: -$41.0 thousand | Fiscal year 2009: -$18.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: